##  [Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder](/us-en/news/media-releases/novartis-gains-fda-approval-signifor-lar-treat-patients-acromegaly-rare-and-life-threatening-hormonal-disorder-0 "Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder") 

  Dec 16, 2014